PESI

Perma-Fix is a small hazardous/nuclear-waste treater whose numbers don't support a $250M market cap. FY2025 revenue grew just 4.3% to $61.7M, and that growth is low-quality: the entire gain came from the Treatment Segment (+29% to $45.1M) while the Services Segment collapsed 31.4% to $16.6M on federal procurement delays tied to the new Administration and the October 2025 government shutdown. Revenue is also lower than it was in FY2021 ($72.2M) and FY2023 ($89.7M), so this is a volatile, government-dependent top line, not a compounder. Profitability is the core problem: 9.7% gross margin, a -19.0% operating margin, a -$13.8M net loss, and a -27.5% ROE. The company has lost money in four of the last five years and carries a -$111M accumulated deficit that grew another 14% this year. Management's own MD&A frames FY2025 as an 'improvement' — but improving from a -$19.6M continuing loss to a -$10.7M one is still deeply unprofitable.

The balance sheet is a mixed picture that leans negative on liquidity. Debt is negligible (LT debt $1.31M, current $562K) and liabilities/equity is a comfortable 0.76x, so there's no near-term solvency crisis. But the company burned $10.8M of operating cash and spent $4.71M on capex in FY2025 — a ~$15.5M free-cash outflow — while equity shrank 19.6% to $50.1M. The only cash figure provided is a stale $1.87M (labeled FY2022), so current liquidity is unavailable from this data, but a business burning this much cash with a pledged-asset credit facility and a lender that bars dividends is one that funds itself with equity — meaning dilution risk for holders.